| Journal | Issue | Title | Abstract | File |
| REMEDIUM | No 10 (2019) | Review of the Russian pharmaceutical market: results of the 1st half of 2019 | Abstract |
 (Rus) |
| Kalinina N. | ||||
| REMEDIUM | No 1 (2021) | Reyting aptechnykh setey Rossii po itogam 2020 goda | Abstract |
(Rus) |
| Bespalov N., Rasshchupkin P. | ||||
| REMEDIUM | No 2 (2021) | Reyting aptechnykh setey Rossii po itogam I kvartala 2021 goda | Abstract |
(Rus) |
| Bespalov N., Rasshchupkin P. | ||||
| REMEDIUM | No 3 (2021) | Reyting aptechnykh setey Rossii po itogam I–II kv. 2021 goda | Abstract |
(Rus) |
| Bespalov N., Rasshchupkin P. | ||||
| REMEDIUM | No 7-8 (2020) | Reyting aptechnykh setey Rossiipo itogam 1-go polugodiya 2020 goda | Abstract |
(Rus) |
| Bespalov N., Rasshchupkin P. | ||||
| REMEDIUM | No 7-8 (2020) | Rezervy polnogo tsikla | Abstract |
(Rus) |
| Kuminova E. | ||||
| REMEDIUM | No 4 (2018) | Risk sharing schemes based on cost-effectiveness of multiple sclerosis disease modifying drugs: foreign experience and the possibilities of its use in Russia | Abstract |
(Rus) |
| Tolkushin A.G., Kholovnya-Voloskova M.E., Andreev D.A., Khachanova N.V., Ermolaeva T.N., Davydovskaya M.V., Kokushkin K.A. | ||||
| REMEDIUM | No 2 (2022) | Risks in the lifestyle of students | Abstract |
(Rus) |
| Gureev S.A., Mingazov R.N., Sadykova R.N., Shegurova K.A. | ||||
| REMEDIUM | No 11 (2018) | Road map and BAA market: forecasts and risks | Abstract |
(Rus) |
| Borzova M. | ||||
| REMEDIUM | No 5 (2019) | Rossiya stanet odnoy iz pervykh stran, pristupivshikh k primeneniyu innovatsionnoy vaktsiny protiv gepatita B | Abstract |
(Rus) |
| Article E. | ||||
| REMEDIUM | No 1-2 (2019) | Rossiyskaya kompaniya nauchila neyroset' iskat' metastazy | Abstract |
(Rus) |
| Article E. | ||||
| REMEDIUM | No 4 (2019) | Rossiyskie vaktsiny otsenili mezhdunarodnye eksperty | Abstract |
(Rus) |
| ShIROKOVA I. | ||||
| REMEDIUM | No 11-12 (2020) | Rossiyskiy farmatsevticheskiy forum o rasshirenii perechnya ZhNVLP | Abstract |
(Rus) |
| Kuminova E. | ||||
| REMEDIUM | No 10 (2019) | Rossiyskiy rynok implantov dlya osteosinteza | Abstract |
(Rus) |
| Vanin A. | ||||
| REMEDIUM | No 10 (2019) | Rossiyskiy rynok rastet blagodarya gossegmentu | Abstract |
(Rus) |
| Shirokova I. | ||||
| REMEDIUM | No 1-2 (2018) | Russia builds the future without tobacco | Abstract |
(Rus) |
| Prozherina J., Shirokova I. | ||||
| REMEDIUM | No 12 (2019) | Russia: export of FPPs at аugust-end 2019 | Abstract |
(Rus) |
| - -. | ||||
| REMEDIUM | No 12 (2019) | Russia: import of FPPs at аugust-end 2019 | Abstract |
(Rus) |
| - -. | ||||
| REMEDIUM | No 3 (2021) | Russian marketing analysis of biologically active additives with pancreatic enzyme | Abstract |
(Rus) |
| Narkevich I.A., Nemyatykh O.D., Basakina I.I., Fitisova A.I. | ||||
| REMEDIUM | No 4-6 (2020) | Russian pharma distributors rating at year-end 2019 | Abstract |
(Rus) |
| Nechaeva Y. | ||||
| REMEDIUM | No 2 (2021) | Russian pharmaceutical market as of the first quarter, 2021 | Abstract |
(Rus) |
| Kalinina N., Shestovets A. | ||||
| REMEDIUM | No 1 (2021) | Russian pharmaceutical market at the end of 2020 | Abstract |
(Rus) |
| Kazova A., Kalinina N. | ||||
| REMEDIUM | No 5 (2018) | Russian pharmaceutical market at the first quarter-end 2018 | Abstract |
(Rus) |
| Denisova M., Prozerina J. | ||||
| REMEDIUM | No 1-3 (2020) | Russian Pharmaceutical Market in 2019 | Abstract |
(Rus) |
| Kalinina N. | ||||
| REMEDIUM | No 13S (2018) | Russian pharmaceutical market: results and forecasts | Abstract |
(Rus) |
| Article E. | ||||
| 451 - 475 of 612 Items | << < 14 15 16 17 18 19 20 21 22 23 > >> | |||